This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Mouse Vascular Endothelial Growth Factor Receptor 2 (Kdr), N-His
Product Overview
BioVenic's Recombinant Mouse Vascular Endothelial Growth Factor Receptor 2 (Kdr), N-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 32.4 kDa. The purity is> 90%.
Specifications
Target Information
Mouse Vascular Endothelial Growth Factor Receptor 2 (KDR) is a receptor tyrosine kinase involved in angiogenesis. It is crucial for the development and maintenance of blood vessels. KDR binds to vascular endothelial growth factors (VEGFs), activating signaling pathways that promote endothelial cell proliferation, survival, and migration. These processes are essential for blood vessel formation during development and wound healing. KDR is also implicated in pathological angiogenesis, such as in cancer, where it supports tumor growth by forming new blood vessels. Targeting KDR has been explored as a therapeutic strategy to inhibit angiogenesis in cancer and other diseases.
Shipping and Storage
This product is shipped with ice packs. Lyophilized protein can be stored at -80°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in ddH2O to a concentration less than or equal to 0.1mg/mL. Do not vortex. Aliquot the reconstituted solution to minimize freeze-thaw cycles.